reporting season

In this video I spoke with Scott Phillips to share an update on small caps reporting this results season. There’s been more beats from an earnings point of view than...

Nanosonics has lived in the shadow of giants like Cochlear for years. Can several near-term growth levers propel the company to new heights?

And it could make for one of the best value plays on today's market.

This ain't your average retailer...

Rumours of a private equity takeover were the story of 2022 for this company. What will 2023 bring?

The travel industry is benefitting from pent up travel demand. But that demand could be threatened if the global slowdown worsens.

Despite recording 20% revenue growth, and a massive cash position, it was a memorandum of understanding that has investors excited for CXL.

Bruce Williams from Elston Asset Management unpacks Santos' results and explains why it is in the Elston Australian Large Companies Fund.

This company is burning cash ahead of a final investment decision around the commencement of a globally significant rare earths project.

Revenues and profits are soaring at this company. It's acquired two stateside rivals. And it's expecting the good times to keep rolling.